Previous Article | Next Article 
Journal of Virology, September 2000, p. 7781-7786, Vol. 74, No. 17
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
A New Mutant Class, Made by Targeted Mutagenesis,
of Phage PRD1 Reveals That Protein P5 Connects the Receptor Binding
Protein to the Vertex
Jaana K. H.
Bamford* and
Dennis H.
Bamford
Department of Biosciences and Institute of
Biotechnology, University of Helsinki, 00014 Helsinki, Finland
Received 29 March 2000/Accepted 5 June 2000
 |
ABSTRACT |
Phage PRD1 and adenovirus share a number of structural and
functional similarities, one of which is the vertex organization at the
fivefold-symmetry positions. We developed an in vitro mutagenesis system for the linear PRD1 genome in order to make targeted mutations. The role of protein P5 in the vertex structure was examined by this
method. Mutation in gene V revealed that protein P5 is
essential. The absence of P5 did not compromise the particle assembly
or DNA packaging but led to a deficient vertex structure where the receptor binding protein P2, in addition to protein P5, was missing. P5
particles also lost their DNA upon purification. Based
on this and previously published information we propose a spatial model for the spike structure at the vertices. This resembles to the corresponding structure in adenovirus.
 |
INTRODUCTION |
Bacteriophage PRD1 is the type virus
of the Tectiviridae family. It infects gram-negative
bacterial hosts provided they harbor an IncP, IncN, or IncW conjugative
plasmid that codes for the virus receptor. The characteristic PRD1
features are the linear double-stranded DNA genome with 5' covalently
linked replication priming proteins and a membrane that resides inside
the icosahedral protein coat (2). The similarities of the
PRD1 major coat protein fold, capsid geometry (T=25), vertex structure,
and replication strategy to those of human adenovirus (10, 11, 15,
16, 20, 21, 34) have led to the surprising conclusion that these viruses share a common ancestry. An additional intriguing feature of
PRD1 is the function of the internal membrane as a device to deliver
the genome into the host cell in a process in which the spherical
membrane transforms into a tube (tail) that is proposed to penetrate
the cell envelope (3, 20, 24, 34).
The 15-kbp viral genome encodes about 25 structural protein species
(8, 18). Disruption studies with guanidine hydrochloride (3) revealed that the major coat protein (P3) and a minor
protein (P5) were released as soluble multimers, the rest of the
proteins being precipitated with the viral membrane. The high number of membrane-associated proteins was surprising, and further studies have
revealed that the structural proteins can be divided into three
categories (in addition to the genome terminal protein): (i) those
forming the outer icosahedral coat, (ii) those responsible for the
integrity of the viral membrane, and (iii) those that are associated
with the DNA delivery to the host cell (34). It seems that
proteins in the last category are not involved in the particle assembly
and that the number of these protein species is close to 10. The
adsorption-DNA delivery proteins seem to be located at or near the
icosahedral vertices (the fivefold symmetry axes) (20, 33,
34).
Extensive attempts have been carried out to select suppressor-sensitive
PRD1 mutants to saturate the genome (26, 34). These mutants
have been invaluable in assigning functions to the corresponding viral
proteins. However, we have not been able to obtain amber mutations to
all of the PRD1 genes, leading to a situation wherein ca. 10 genes are
without mutations. Targeted in vitro mutagenesis is an obvious approach
to address the rest of the genes. However, due to the linear form and
the difficulties in dealing with the hydrophobic terminal proteins of
the genome, there has been no success thus far in these attempts.
One of the genes for which no mutants have been isolated is gene
V. It is a 1,023-bp gene encoding a 34-kDa protein P5. The gene sequence revealed that the protein contained an internal collagen-like domain (gly-x-y)6, which could be cleaved
with collagenase (6). This observation suggested an ancient
evolutionary history for the collagenous protein architecture widely
utilized in eukaryotic cells (1). The purified recombinant
P5 protein (as well as the one isolated from the virion) is a soluble
trimer. It is composed of an N-terminal smaller domain that has
sequence similarity to the pentameric vertex protein P31 and a
C-terminal larger domain that is responsible for the trimerization of
the protein (J. Caldentey, R. Tuma, and D. H. Bamford, submitted
for publication). These domains are connected by the collagen-like
region, followed by a glycine-rich stretch of amino acids. In solution
purified P5 trimers slowly form higher-order multimers and a
heterocomplex with protein P31 (Caldentey et al., submitted). Also,
yeast two-hybrid analyses have revealed interactions between the
smaller N-terminal domain of P5 and protein P31 (M. Aalto, personal communication).
In this study we describe a site-directed mutagenesis system for PRD1.
Using this technology we have generated amber mutations in gene
V. P5
mutants are not compromised in particle
formation or DNA packaging but are deficient in DNA retention and
delivery as well as in assembly of the receptor binding protein P2 to
the fivefold vertex.
 |
MATERIALS AND METHODS |
Bacteria, phages, and plasmids.
The bacterial strains used
in this study are listed in Table 1.
Cells were grown in Luria-Bertani (LB) medium (35). When appropriate, tetracycline (10 µg/ml), streptomycin (100 µg/ml), or
chloramphenicol (25 µg/ml) was added. PRD1 was propagated on Salmonella enterica serovar Typhimurium strain DS88 or on a
suppressor strain, PSA(pLM2). The purification of the virus was done as
described earlier (7). Wild-type and mutant viruses were
labeled with 14C-labeled amino acids and purified as
described previously (23). The plasmids and phages used are
listed in Table 2.
DNA cloning.
Standard DNA cloning techniques were performed
according to the method of Sambrook et al. (35). The genes
and DNA fragments were amplified using Pfu polymerase
(Stratagene) and specific primers with designed restriction enzyme
recognition sequences. The region of PRD1 genome (nucleotide
coordinates 4894 to 6309 [8]) containing the
structural genes XXXI and V was amplified using
the viral DNA as a template. The fragment was purified from low-melting-point agarose gel and ligated into pSU18 vector under the
lac promoter, resulting in plasmid pJB500. Using pJB500 as a
template, a BamHI site was generated using the QuikChange
site-directed mutagenesis kit (Stratagene) at the beginning of gene
V (position 5305 in the PRD1 genome), resulting in plasmid
pJB501. Chromosomal DNA from Escherichia coli JE2571
(14), carrying the wild-type
-galactosidase gene, was
isolated and used as a template to amplify the lacZ
fragment. The fragment was cloned into the BamHI site of
pJB501, and the resulting plasmid was named pJB504. Using plasmid pJB500, carrying the wild-type gene V, as a template the in
vitro mutagenesis method was used to introduce an amber mutation into the beginning of gene V (5299) corresponding to the Q4
residue in protein P5. The resulting plasmid was named pJB515.
Construction of recombinant phages.
PRD1 genomic DNA with
the covalently bound terminal proteins was isolated as previously
described (25). The DNA was digested with PacI
restriction enzyme cleaving the genome once, between genes V
and XVII, at position 6306. The amplified lacZ
fragment was ligated with the PacI-cleaved genome and
transfected by electroporation (25) into JM107(pJB15)
cells and plated on LB agar with 30 µg of
5-bromo-4-chloro-3-indolyl-
-D-galactoside (X-Gal) per ml
and 1 mM isopropyl-
-D-thiogalactopyranoside (IPTG).
Three blue plaques were obtained, one of which was purified and named
PRD1[lacZ
]-1.
In another construction, the lacZ
fragment was introduced
into the virus genome by homologous recombination between the wild-type (wt) genome and plasmid pJB504. To obtain the recombinant virus, strain
JM107(pJB15)(pJB504) was infected with wt PRD1 to make semiconfluent
plates. The soft agar layer was transferred into a beaker, and growth
was continued for 4 h at 37°C. The lysate was cleared by
centrifugation, and the supernatant was plated on complementing strain
JM107(pJB15)(pJB500). Three blue plaques were obtained; one was further
purified on DH5
(pJB15)(pJB500) and named
PRD1[lacZ
]-5.
Homologous recombination was further used to exchange the
lacZ
fragment in the genome of
PRD1[lacZ
]-5 to an amber mutation constructed into the
recombinant plasmid. The suppressor strain JM107(pJB15) containing
plasmid pJB515 was infected with PRD1[lacZ
]-5, and
homologous recombination was allowed to occur during growth as
described above. The cleared lysate was plated on the serovar Typhimurium PSA suppressor strain, and plaques were screened for a
suppressor-sensitive phenotype by picking them on the lawns of PSA and
DS88 hosts. One of the obtained amber mutant phages was named
sus690. Amber codons were also introduced into three other
locations in gene V: TAG codons were generated by in vitro mutagenesis in plasmid pJB500 in positions 5734, 5836, and 5896 in the
PRD1 genomic sequence, resulting in plasmids pJB521, pJB523, and
pJB525, respectively, and the mutations were introduced into the
PRD1[lacZ
]-5 genome. The corresponding recombinant
phages were named sus691, sus692, and
sus693, respectively.
Phage adsorption test.
The adsorption assay was, in
principle, carried out as previously described (20, 23).
Receptor-less (SL5676) and receptor-containing (DS88) cells were grown
in LB medium to approximately 2 × 109 CFU/ml (the
optimal adsorption phase [23]). The binding of the wt
PRD1, sus539 (P2
), and sus690
(P5
) particles to the cells was measured by using
14C-labeled particles. About 6,000 cpm (3.5 × 10
5 cpm/PFU) of labeled wt virus particles corresponding
to a multiplicity of infection (MOI) of 1 were used. The number of the
labeled noninfectious mutant viruses was calculated by using the
protein concentration of the preparations. The 6,000 cpm of mutant
particles used in the assay corresponded to an MOI of ca. 30. Bacterial
cells (100 µl) were mixed with the labeled virus and incubated for 15 min at room temperature. The cells were collected (Heraeus Biofuge pico; room temperature, 3 min, 20,000 × g), washed
twice with 100 µl of LB medium, and finally resuspended into 100 µl
of LB medium. The supernatants and the pellet fraction were collected, and the radioactivity was measured by liquid scintillation counting.
Electron microscopy methods.
For thin-section electron
microscopy serovar Typhimurium DS88 was grown to a density of
109 CFU/ml and infected with sus690 phage stock
(grown on PSA) using an MOI of 9. Samples were taken at 30, 55, 70, and
100 min postinfection and fixed with 3% (vol/vol) glutaraldehyde in 20 mM potassium phosphate buffer (pH 7.2). After 30 min of incubation at
room temperature, the cells were collected by centrifugation, washed twice, and prepared for transmission electron microscopy as described elsewhere (4). The micrographs were taken with a JEOL 1200 EX electron microscope (at the electron microscopy unit, Institute of
Biotechnology, University of Helsinki) operating at 60 kV. For
negative-staining electron microscopy, the purified virus particles
were stained on carbon-coated grids with 1% phosphotungstic acid (pH
6.5) for 15 s, blotted dry, and examined under electron microscopy
as described above.
Analytical methods.
Sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) was performed as described earlier
(30). The proteins were either stained with Coomassie
brilliant blue or transferred from the gel onto a polyvinylidene
difluoride membrane (Millipore) and then detected with antibodies.
Polyclonal antisera recognizing proteins P5 (22), P2
(20), and P31 (34) and the monoclonal antibodies
6T56, 7T41, and 18T56 (detecting proteins P6, P7, and P18, respectively
[22]) were used. The chemiluminescent detection of
peroxidase-conjugated secondary antibodies was performed using the
EZ-ECL Detection Kit (Biological Industries). The protein concentration
of the virus preparates was determined according to the method of
Bradford (13) using bovine serum albumin as a standard.
 |
RESULTS |
PRD1 can package extra DNA.
The ability of the PRD1 genome to
express the lacZ
fragment (393 bp) and to package this
extra DNA was tested by inserting it into the unique PacI
site between the genes V and XVII. The lacZ
fragment DNA, including the promoter, was amplified
by PCR, and inserted into the PacI-cleaved genome. When
plated on strain JM107(pJB15) producing the complementing O fragment of
LacZ, this phage was able to make blue plaques, revealing that the
promoter of lacZ was functional in the virus genome.
However, the titer of the recombinant phage was about 1 order of
magnitude lower than the titer of the wt phage (1.6 × 1010 and 2.5 × 1011, respectively).
Restriction enzyme analysis of the resulting recombinant phage DNA,
PRD1[lacZ
]-1, confirmed that the fragment was inserted
into the genome oriented in the opposite direction from the rest of the
PRD1 genes (data not shown).
P5 is essential for virus infectivity.
We tested whether P5 is
essential for virus infectivity. This was done by disrupting gene
V by a lacZ
insertion. The fragment was first
cloned close to the beginning of gene V in plasmid pSU18 and
then introduced into the virus genome by in vivo homologous recombination between the linear virus genome and the circular plasmid.
Blue plaques were obtained, but the color was lost during plaque
purification. Either the fragment was not stably maintained in the
genome or the expression of the fragment was abolished due to
mutations. Restriction enzyme digestions of the isolated recombinant
virus genome revealed that the fragment was still in gene V
(data not shown), favoring the second alternative. The titer of the
recombinant phage, PRD1[lacZ
]-5, was about 500 times lower on the noncomplementing DH5
(pJB15) strain than on the
corresponding strain containing the complementing plasmid pJB500,
suggesting that protein P5 is essential.
The lacZ
insertion, which inactivated gene V,
was further used as a marker when introducing the amber codon from
plasmid pJB515 to the virus genome by in vivo homologous recombination. During the growth of PRD1[lacZ
]-5 on a suppressor
strain containing pJB515, the resulting recombinant phages representing
the wt phenotype were enriched. The virus pool obtained was plated on
strain PSA to suppress the amber mutation, and the plaques were
screened by picking them on DS88 and PSA lawns. Three mutants out of
150 plaques tested (one of which was sus690 [see below])
were obtained, revealing that the recombination frequency and the rate
of enrichment were fairly good. The titers of the mutants were
determined on the nonsuppressing strains HMS174(pLM2) and
HMS174(pLM2)(pJB500). The mutant phenotype could be rescued when
protein P5 was provided in trans, the titers being
approximately 2 × 105 and 8 × 1011
on the noncomplementing and complementing strains, respectively. This
finding confirmed that the defect was in gene V.
Accordingly, protein P5 was missing when the sucrose-gradient-purified
mutant virus was analyzed by SDS-PAGE with Coomassie staining (data not shown). However, a small amount of P5 was detected on Western blots
with polyclonal anti-P5 serum (Table 3
and Fig. 1). For this reason, decreasing
amounts of purified wt and mutant virus particles were analyzed by
Western blotting using polyclonal P5 antiserum. On the basis of this
analysis the amount of P5 was about 50 times lower in the amber mutant
than in the wt virus (Table 3). Except for P2, all other PRD1 proteins
were present in wt amounts, as judged from SDS-PAGE gels stained with
Coomassie brilliant blue or detected with available specific
antibodies. The amount of P2 (62 kDa) was found to be about 50 times
lower in the mutant compared to the wt virus using Western blotting and
polyclonal P2 antiserum (Table 3).
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Proportion of P5, the amber fragment of P5 (P5*), P2, and
P31 in mutant virus particles compared to the
wt particlea
|
|

View larger version (94K):
[in this window]
[in a new window]
|
FIG. 1.
Immunological identification of proteins P2 and P5 from
serial dilutions of purified virus particles analyzed by SDS-PAGE. The
highest amount applied to the gel was 20 µg of protein.
|
|
P5 stabilizes the interaction of the receptor-binding protein P2
with the particle.
Since the amount of the spike protein P2 in
gene V amber mutant sus690 was diminished, the
adsorption efficiency of the mutant was tested. wt and mutant particles
missing protein P2 (sus539) were used as controls. The
adsorption test was carried out by binding 14C-labeled
virus particles both to the receptor-less SL5676 and to
receptor-containing DS88 cells. The adsorption level of the wt
particles to DS88 cells was ca. 50% and to the SL5676 cells was ca.
1.3%, corresponding well with the earlier reported values (20,
23). sus690 particles clearly displayed no binding to the cells (adsorption level of 0.6% to DS88 cells), which was also the
case with the control mutant sus539 (adsorption level of
2.6% to DS88 cells). The results support the finding that P5 is needed
for infectivity, most probably due to its role in stabilizing P2
interaction with the particle.
Gene V mutations do not interfere with particle
formation or packaging of the DNA.
Nonsuppressing DS88 cells were
infected with sus690, grown on the suppressor strain PSA,
and samples were taken for thin-section electron microscopy at
different time points postinfection. The mutant infection followed that
of the wt one, yielding a large number of DNA filled particles at the
end of the infection cycle (Fig. 2).
Although almost all of the intracellular particles appeared to contain
DNA, as seen in the thin-section electron micrographs (Fig. 2), only
about 50% were filled after purification by rate zonal sucrose
gradient centrifugation. This was estimated from the intensities of the
slow- and fast-moving light-scattering bands in sucrose gradients
representing the empty and filled particles, respectively (data not
shown). In the case of the wt virus the proportion of filled particles
is about 80% (5). Negative staining of the purified mutant
virus revealed that the appearance of both the filled and the empty
particles was identical to the corresponding wt particles (Fig.
3). Surprisingly, no tail structures were
detected, although these structures are readily seen in the case of the mutant particles missing the spike protein P2 (20). The tail formation is associated with membrane transformation upon DNA release
(3, 20, 34).

View larger version (138K):
[in this window]
[in a new window]
|
FIG. 2.
Electron micrographs of thin-sectioned DS88 cells
infected with sus690. (A) Image obtained 30 min after
infection. The arrows point to an adsorbed and an intracellular empty
particle. (B) Image obtained 70 min postinfection showing a large
number of peripheral filled particles. Bar, 300 nm.
|
|

View larger version (119K):
[in this window]
[in a new window]
|
FIG. 3.
Negative-staining electron micrograph of purified
sus690 viruses showing filled (A) and empty, DNA-less (B)
particles. Bar, 100 nm.
|
|
The amino-terminal domain of P5 is attached to the particle.
Genes XXXI (381 nucleotides [nt]) and V (1,023 nt) are organized as an operon (OL1 [19]) in the PRD1
genome. Gene V can be divided into two parts, which are
separated by a linker region encoding a collagen-like helix, a flexible
area, and a glycine-rich stretch (reference 6 and
Fig. 4). Comparison of the two genes at the nucleotide level showed
that gene XXXI has 48.1% identity to the sequence encoding
the amino-terminal part and 35.7% identity to the sequence encoding
the carboxy-terminal part of P5. The sequences encoding the amino- and
carboxy-terminal parts of protein P5 display 43% identity with each
other. This shows that these two regions of gene V could be
originating from gene XXXI or vice versa. In a recent study,
the carboxy-terminal domain of P5 has been proposed to be involved in
the trimerization of the protein (Caldentey et al., submitted). In that
study it was shown that, after digesting the purified protein with
collagenase into two parts, the 135-residue amino-terminal part appears
to be monomeric and the 205-residue carboxy-terminal part retains its
trimeric form. We made DNA constructions with amber mutations in gene
V producing three amino-terminal fragments of different
lengths and recombined them into the virus genome in order to see
whether the truncated molecules will be degraded or rescued by the
subsequent assembly to the particle. The shortest truncated polypeptide
(mutation S150am) was designed to be 149 amino acids long,
containing the N-terminal domain and the collagen-like helix; the
second (Q184am) ended before the glycine-rich stretch, and
the third (S204am) contained the entire linker region (Fig.
4).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 4.
Late operon OL1 of PRD1 (nt 4894 to 6309 [8,
19]). Transcription is from left to right. The horizontal
positions of the genes indicate the different reading frames. Gene
XXXI encodes the penton protein, and gene V
encodes the vertex protein. The function of open reading frame d (orf
d) is not known at the moment. Gene V has 5'- and
3'-terminal parts which are separated by a linker region. The linker
region can be divided into three parts on the basis of the amino acids
it encodes (gray boxes). The first (on the left) contains the
collagen-like helix, the one on the right has eight glycines in a row,
and the area between these two parts seems to be flexible, with many
glycine and serine residues. The positions of the created amber
mutations are indicated with arrows.
|
|
The different truncated P5 polypeptides were overexpressed from plasmid
constructions in HMS174 (nonsuppressor) cells. These constructions
produced large amounts of recombinant proteins, as seen in SDS-PAGE
gels with Coomassie brilliant blue staining. The apparent molecular
weights of the amber fragments corresponded to those calculated from
the truncated polypeptide sequence (data not shown). We examined the
multimeric state of the amber fragments in conditions in which P5
retains its trimeric form. This was done by omitting the boiling step
in SDS prior to loading the samples on top of an SDS-PAGE gel (22,
27). The amber fragments were detected only in monomeric and not
in higher-molecular-weight forms, in contrast to the full-length P5,
which was seen in this assay as migrating in both forms (data not shown).
The ability of the truncated P5 polypeptides to assemble into the virus
particle was determined by analyzing the purified recombinant viruses
sus691, sus692, and sus693
(S150am, Q184am, and S204am,
respectively). Surprisingly, in sucrose gradients the mutants behaved
like the wt virus, yielding 80% of filled particles, in contrast to
sus690 (Q4am), which only yielded 50%. This
indicates that the shortened P5 fragments are able to seal the
particle, thus preventing DNA leakage upon purification. It was shown
by Western blotting that the truncated P5 molecules assembled into the
virus particle (Table 3). Low amounts of full-length P5 were also
associated with the particles due to the leakiness of the amber
mutations. The amount of the full-length polypeptide was determined to
be the same as the amount of the truncated molecule in the case of
sus692, encoding the middle-length truncation (Table 3). The
shorter and the longer amber fragments (sus691 and
sus693, respectively) were able to compete with the
full-length P5 upon assembly, as can be seen in Table 3. The amount of
the full-length P5 in sus691, sus692, and
sus693 was clearly diminished compared to
sus690r, meaning that the particle-sealing effect was
achieved upon assembly of the fragments alone and not by the coassembly of the full-length polypeptide with the amber fragment. These results
also suggest that P5 is oriented so that the amino-terminal portion is
associated with the virus capsid.
 |
DISCUSSION |
Current progress in establishing methods for creating
site-directed amber mutations within the PRD1 genome opens up the
possibility for testing the essentiality of the genes as well as for
obtaining information about the functions of genes for which no
classical mutations are available. The general usefulness of the
targeted mutagenesis method in PRD1 will depend on (i) the
recombination frequency in different genomic regions and (ii) the
phenotype of the resulting mutant, since the enrichment of the mutant
viruses during recombination is based on the selective advantage of the suppressed phenotype over the mutant one. We are also developing methods to delete entire genes. This will in the future extend the
genetic analysis of PRD1 to applications where the leakiness of amber
mutations presents a major obstacle. It has been shown with LacI-LacZ
fusion proteins containing amber codons that the wt background in a
nonsuppressing Salmonella strain can be as high as 2%
(12). This finding is in agreement with the amount of the
full-length P5 found in the mutant sus690 particle (1/50 of
that found in the wt).
The high sequence similarity between the DNA regions encoding the
amino- and carboxy-terminal parts of P5 and the vertex penton protein
P31 suggests a single gene origin for all of these elements. Both P31
and P5 form homomultimers, and these interact with each other
(6, 34; Caldentey et al., submitted). Using the same structural elements utilizing gene multiplication to conserve interactions when building increasingly complex structures is an
intriguing phenomenon.
We have previously used the PRD1-adenovirus analogy successfully in
revealing the PRD1 penton protein (P31) location at the fivefold-symmetry positions of the capsid (34). The
adenovirus spike protein (IV) is an elongated trimeric structure with a
distal receptor-binding knob (32). It extends from the
pentameric penton base protein (III), creating a symmetry missmatch
considered to be important in forming a metastable structure utilized
in receptor binding, virus entry, and DNA delivery (36, 29).
The vertex structure of PRD1 is much less characterized. Mutational
analysis has revealed that in the absence of the penton protein P31,
proteins P2 (the adsorption protein) and P5 are also absent, in
addition to the peripentonal ring of coat protein trimers
(34). Protein P5 was previously shown to be accessible on
the virus surface (22). Isolated protein P2 was shown to be
monomeric and readily bound to the PRD1 receptor on the host cell
surface (20).
We have demonstrated here that in the absence of protein P5
(sus690), the penton protein P31 is present and the
adsorption protein P2 is absent and that there is no effect on the
virion assembly or on DNA packaging. It has been shown earlier that, in
the absence of protein P2, the viral particles are assembled and
packaged but that upon storage release the DNA and that this release is
related to the membrane transformation into a tube (20).
sus690 mutant phage appeared to lose the DNA upon
purification, resulting in reduced amounts of filled particles. With
negative-staining electron microscopy of the purified particles, we
showed here that the membrane transformation to a tail structure is not
enhanced in the mutant (as is the case with the P2-deficient mutant),
indicating that the loss of DNA probably occurs through an opening in
the vertex and not via membrane transformation. Taking all of this information into account, we propose a model wherein the trimeric P5 is
associated with the pentameric P31 and in which P2 is the most distal
component of the spike structure connected to P5. Thus, P5 would be
functionally analogous to the adenovirus spike shaft, and P2 would
correspond the adenovirus spike knob (and maybe part of the shaft). In
both viruses there is a symmetry missmatch at the vertex that is
important in the infection process. We have previously demonstrated
that part of protein P2 is associated with the virus membrane fraction
after removal of the major coat protein P3 and protein P5 with
guanidine hydrochloride (3). Whether there is also a direct
contact between P2 and the penton base protein P31 or whether this
result is due to unspecific interactions of these proteins upon
denaturation awaits the ongoing structure determinations of the virion
and its spike components.
All of the N-terminal P5 fragments obtained here were found to be
associated with the virion and alleviated the unstable DNA packaging
phenotype of the P5 (and P2)-deficient particles. This indicates that
the N-terminal portion of P5 is proximal to the virus surface. The
leakage of DNA from P5-deficient particles also implies that P5 sits at
the fivefold-symmetry position, preventing DNA release. We can assume a
model for the DNA release wherein the process is initiated by the
binding of P2 to the primary receptor followed by binding of P5 to a
possible secondary receptor, leading to the subsequent triggering of
the membrane tail tube formation. Again, there is a resemblance to the
two-step adenovirus infection mechanism, in which the fiber protein
first mediates attachment to cells via interaction with CAR (adenovirus
and coxsackievirus receptor). The second interaction between the
penton base and the cell integrins promotes the virus internalization.
 |
ACKNOWLEDGMENTS |
This study was supported by research grants 162993 and 164298 (Finnish Centre of Excellence Programme [2000-20005]) from the Academy of Finland and grant 40857 from the Technology Development Center of Finland (D.H.B.).
We thank Marja-Leena Perälä for excellent technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biosciences, P.O. Box 56 (Viikinkaari 5), University of Helsinki, 00014 Helsinki, Finland. Phone: 358-9-19159101. Fax: 358-9-19159098. E-mail:
jaana.bamford{at}helsinki.fi.
 |
REFERENCES |
| 1.
|
Bamford, D. H., and J. K. H. Bamford.
1990.
Collagenous proteins multiply.
Nature
344:497.
|
| 2.
|
Bamford, D. H.,
J. Caldentey, and J. K. H. Bamford.
1995.
PRD1: a broad host range dsDNA tectivirus with an internal membrane.
Adv. Virus Res.
45:281-319[Medline].
|
| 3.
|
Bamford, D. H., and L. Mindich.
1982.
Structure of the lipid containing bacteriophage PRD1: disruption of wild-type and nonsense mutant phage particles with guanidine hydrochloride.
J. Virol.
44:1031-1038[Abstract/Free Full Text].
|
| 4.
|
Bamford, D. H., and L. Mindich.
1982.
Electron microscopy of cells infected with nonsense mutants of bacteriophage 6.
Virology
710:222-228.
|
| 5.
|
Bamford, D. H.,
L. Rouhiainen,
K. Takkinen, and H. Söderlund.
1981.
Comparison of the lipid-containing bacteriophages PRD1, PR3, PR4, PR5, and L17.
J. Gen. Virol.
57:365-373[Abstract/Free Full Text].
|
| 6.
|
Bamford, J. K. H., and D. H. Bamford.
1990.
Capsomer proteins of bacteriophage PRD1, a bacterial virus with a membrane.
Virology
177:445-451[CrossRef][Medline].
|
| 7.
|
Bamford, J. K. H., and D. H. Bamford.
1991.
Large scale purification of membrane-containing bacteriophage PRD1 and its subviral particles.
Virology
181:348-352[CrossRef][Medline].
|
| 8.
|
Bamford, J. K. H.,
A.-L. Hänninen,
T. M. Pakula,
P. M. Ojala,
N. Kalkkinen,
M. Frilander, and D. H. Bamford.
1991.
Genome organization of PRD1, a membrane-containing bacteriophage infecting E. coli.
Virology
183:658-676[CrossRef][Medline].
|
| 9.
|
Bartolomé, B.,
Y. Jubete,
E. Martínez, and F. de la Cruz.
1991.
Construction and properties of a family of pACYC184-derived cloning vectors compatible with pBR322 and its derivatives.
Gene
102:75-78[CrossRef][Medline].
|
| 10.
|
Belnap, D. M., and A. C. Steven.
2000.
`Déjá vu all over again': the similar structures of bacteriophage PRD1 and adenovirus.
Trends Microbiol.
8:91-93[CrossRef][Medline].
|
| 11.
|
Benson, S.,
J. K. H. Bamford,
D. H. Bamford, and R. M. Burnett.
1999.
Viral evolution revealed by bacteriophage PRD1 and human adenovirus coat protein structures.
Cell
98:825-833[CrossRef][Medline].
|
| 12.
|
Bossi, L.
1983.
Context effects: translation of UAG codon by suppressor tRNA is affected by the sequence following UAG in the message.
J. Mol. Biol.
164:73-87[CrossRef][Medline].
|
| 13.
|
Bradford, M. M.
1976.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:248-254[CrossRef][Medline].
|
| 14.
|
Bradley, D. E.
1980.
Morphological and serological relationship of conjugative pili.
Plasmid
4:155-169[CrossRef][Medline].
|
| 15.
|
Burnett, R. M.
1997.
The structure of adenovirus, p. 209-238.
In
W. Chiu, R. M. Burnett, and R. L. Garcea (ed.), Structural biology of viruses. Oxford University Press, Inc., New York, N.Y.
|
| 16.
|
Butcher, S. J.,
D. H. Bamford, and S. D. Fuller.
1995.
DNA packaging orders the membrane of bacteriophage PRD1.
EMBO J.
14:6078-6086[Medline].
|
| 17.
|
Cambell, J. L.,
C. C. Richardson, and F. W. Studier.
1978.
Genetic recombination and complementation between bacteriophage T7 and cloned fragments of T7 DNA.
Proc. Natl. Acad. Sci. USA
75:2276-2280[Abstract/Free Full Text].
|
| 18.
|
Davis, T. N.,
E. Muller, and J. E. Cronan, Jr.
1982.
The virion of the lipid-containing bacteriophage PR4.
Virology
120:287-306[CrossRef][Medline].
|
| 19.
|
Grahn, A. M.,
J. K. H. Bamford,
M. O'Neill, and D. H. Bamford.
1994.
Functional organization of bacteriophage PRD1 genome.
J. Bacteriol.
176:3062-3068[Abstract/Free Full Text].
|
| 20.
|
Grahn, A. M.,
J. Caldentey,
J. K. H. Bamford, and D. H. Bamford.
1999.
Stable packaging of phage PRD1 DNA requires adsorption protein P2, which binds to the IncP plasmid-encoded conjugative transfer complex.
J. Bacteriol.
181:6689-6696[Abstract/Free Full Text].
|
| 21.
|
Hendrix, R. W.
1999.
Evolution: the long evolutionary reach of viruses.
Curr. Biol.
9:R914-R917[CrossRef][Medline].
|
| 22.
|
Hänninen, A.-L.,
D. H. Bamford, and J. K. H. Bamford.
1997.
Probing the phage PRD1 specific proteins during infection by monoclonal and polyclonal antibodies.
Virology
227:198-206[CrossRef][Medline].
|
| 23.
|
Kotilainen, M. M.,
A. M. Grahn,
J. K. H. Bamford, and D. H. Bamford.
1993.
Binding of an Escherichia coli dsDNA virus PRD1 to a receptor coded by an IncP-type plasmid.
J. Bacteriol.
175:3089-3095[Abstract/Free Full Text].
|
| 24.
|
Lundström, K. H.,
D. H. Bamford,
E. Palva, and K. Lounatmaa.
1979.
Lipid-containing bacteriophage PR4: structure and life cycle.
J. Gen. Virol.
43:583-592[Abstract/Free Full Text].
|
| 25.
|
Lyra, C.,
H. Savilahti, and D. H. Bamford.
1991.
High-frequency transfer of linear DNA containing 5'-covalently linked terminal proteins: electroporation of bacteriophage PRD1 genome into Escherichia coli.
Mol. Gen. Genet.
228:65-69[Medline].
|
| 26.
|
Mindich, L.,
D. H. Bamford,
C. Goldthwaite,
M. Laverty, and G. MacKenzie.
1982.
Isolation of nonsense mutants of lipid-containing bacteriophage PRD1.
J. Virol.
44:1013-1020[Abstract/Free Full Text].
|
| 27.
|
Mindich, L.,
D. H. Bamford,
T. M. McGraw, and G. MacKenzie.
1982.
Assembly of bacteriophage PRD1: particle formation with wild-type and mutant viruses.
J. Virol.
44:1021-1030[Abstract/Free Full Text].
|
| 28.
|
Mindich, L.,
J. Cohen, and M. Weisburd.
1976.
Isolation of nonsense suppressor mutants in Pseudomonas.
J. Bacteriol.
126:177-182[Abstract/Free Full Text].
|
| 29.
|
Nemerow, G. R., and P. L. Stewart.
1999.
Role of v integrins in adenovirus cell entry and gene delivery.
Microbiol. Mol. Biol. Rev.
63:725-734[Abstract/Free Full Text].
|
| 30.
|
Olkkonen, V. M., and D. H. Bamford.
1989.
Quantitation of the adsorption and penetration stages of bacteriophage 6 infection.
Virology
171:229-238[CrossRef][Medline].
|
| 31.
|
Olsen, R. H.,
J.-S. Siak, and R. H. Gray.
1974.
Characteristics of PRD1, a plasmid-dependent broad host range DNA bacteriophage.
J. Virol.
14:689-699[Abstract/Free Full Text].
|
| 32.
|
Philipson, L.,
K. Lonberg-Holm, and U. Petterson.
1968.
Virus-receptor interaction in an adenovirus system.
J. Virol.
2:1064-1075[Abstract/Free Full Text].
|
| 33.
|
Rydman, P. S., and D. H. Bamford.
2000.
Bacteriophage PRD1 DNA entry utilizes a viral membrane associated transglycosylase activity.
Mol. Microbiol.
37:356-364[CrossRef][Medline].
|
| 34.
|
Rydman, P. S.,
J. Caldentey,
S. J. Butcher,
S. D. Fuller,
T. Rutten, and D. H. Bamford.
1999.
Bacteriophage PRD1 contains a labile receptor binding structure at each vertex.
J. Mol. Biol.
291:575-587[CrossRef][Medline].
|
| 35.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 36.
|
Wickham, T. J.,
P. Mathias,
D. A. Cheresh, and G. R. Nemerow.
1993.
Integrins v 3 and v 5 promote adenovirus internalization but not virus attachment.
Cell
73:309-319[CrossRef][Medline].
|
| 37.
|
Yanisch-Perron, C.,
J. Vieira, and J. Messing.
1985.
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.
Gene
33:103-119[CrossRef][Medline].
|
Journal of Virology, September 2000, p. 7781-7786, Vol. 74, No. 17
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Huiskonen, J. T., Manole, V., Butcher, S. J.
(2007). Tale of two spikes in bacteriophage PRD1. Proc. Natl. Acad. Sci. USA
104: 6666-6671
[Abstract]
[Full Text]
-
Karhu, N. J., Ziedaite, G., Bamford, D. H., Bamford, J. K. H.
(2007). Efficient DNA Packaging of Bacteriophage PRD1 Requires the Unique Vertex Protein P6. J. Virol.
81: 2970-2979
[Abstract]
[Full Text]
-
Ziedaite, G., Daugelavicius, R., Bamford, J. K. H., Bamford, D. H.
(2005). The Holin Protein of Bacteriophage PRD1 Forms a Pore for Small-Molecule and Endolysin Translocation. J. Bacteriol.
187: 5397-5405
[Abstract]
[Full Text]
-
Bamford, D. H., Ravantti, J. J., Ronnholm, G., Laurinavicius, S., Kukkaro, P., Dyall-Smith, M., Somerharju, P., Kalkkinen, N., Bamford, J. K. H.
(2005). Constituents of SH1, a Novel Lipid-Containing Virus Infecting the Halophilic Euryarchaeon Haloarcula hispanica. J. Virol.
79: 9097-9107
[Abstract]
[Full Text]
-
Jaatinen, S. T., Viitanen, S. J., Bamford, D. H., Bamford, J. K. H.
(2004). Integral Membrane Protein P16 of Bacteriophage PRD1 Stabilizes the Adsorption Vertex Structure. J. Virol.
78: 9790-9797
[Abstract]
[Full Text]
-
Gowen, B., Bamford, J. K. H., Bamford, D. H., Fuller, S. D.
(2003). The Tailless Icosahedral Membrane Virus PRD1 Localizes the Proteins Involved in Genome Packaging and Injection at a Unique Vertex. J. Virol.
77: 7863-7871
[Abstract]
[Full Text]
-
Stromsten, N. J., Bamford, D. H., Bamford, J. K. H.
(2003). The Unique Vertex of Bacterial Virus PRD1 Is Connected to the Viral Internal Membrane. J. Virol.
77: 6314-6321
[Abstract]
[Full Text]
-
Vilen, H., Aalto, J.-M., Kassinen, A., Paulin, L., Savilahti, H.
(2002). A Direct Transposon Insertion Tool for Modification and Functional Analysis of Viral Genomes. J. Virol.
77: 123-134
[Abstract]
[Full Text]
-
Grahn, A. M., Daugelavicius, R., Bamford, D. H.
(2002). The Small Viral Membrane-Associated Protein P32 Is Involved in Bacteriophage PRD1 DNA Entry. J. Virol.
76: 4866-4872
[Abstract]
[Full Text]
-
Sokolova, A., Malfois, M., Caldentey, J., Svergun, D. I., Koch, M. H. J., Bamford, D. H., Tuma, R.
(2001). Solution Structure of Bacteriophage PRD1 Vertex Complex. J. Biol. Chem.
276: 46187-46195
[Abstract]
[Full Text]